Influenza virus-IN-7 structure
|
Common Name | Influenza virus-IN-7 | ||
---|---|---|---|---|
CAS Number | 2703046-92-6 | Molecular Weight | 612.60 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C29H26F2N4O7S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Influenza virus-IN-7Influenza virus-IN-7 (Example 16) is an orally active cap-dependent endonuclease inhibitor that can be used for the research of influenza viral infectious diseases[1]. |
Name | Influenza virus-IN-7 |
---|
Description | Influenza virus-IN-7 (Example 16) is an orally active cap-dependent endonuclease inhibitor that can be used for the research of influenza viral infectious diseases[1]. |
---|---|
Related Catalog | |
Target |
IC50: Cap-dependent endonuclease[1] |
In Vitro | Influenza virus-IN-7 (Example 16) 在 MDCK 细胞中显示出对流感 A/Weiss/43(H1N1) 病毒的抗病毒活性,EC50 为 <5 nM (CC50 >1000 nM)[1]。 |
In Vivo | Influenza virus-IN-7 (Example 16; 5 mg/kg; i.g.; twice daily for 5 days) 可提高 WSN/33 (H1N1) 感染小鼠模型的存活率[1]。 Animal Model: WSN/33 (H1N1) infection mouse model[1] Dosage: 5 mg/kg Administration: Intragastric administration, twice daily for 5 days Result: Significantly improved the survival rate. |
References |
Molecular Formula | C29H26F2N4O7S |
---|---|
Molecular Weight | 612.60 |